livtencity
takeda pharmaceuticals international ag ireland branch - maribavir - infekcije citomegalovirusa - antivirusni lijekovi za sustavnu uporabu - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). treba uzeti u obzir formalne preporuke za odgovarajuće korištenje antivirusnih lijekova.
pyrukynd
agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.
vafseo
akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - antianemijski pripravci - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.
santuril 500mg tableta
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - probenecid - tableta - 500mg
dasatinib pharmascience 20mg film tableta
"evropa lek pharma" doo podgorica - dasatinib - film tableta - 20mg
dasatinib pharmascience 100mg film tableta
"evropa lek pharma" doo podgorica - dasatinib - film tableta - 100mg
dasatinib zentiva 140mg film tableta
zentiva pharma doo - dio stranog druŠtva podgorica - dasatinib - film tableta - 140mg
dasatinib zentiva 100mg film tableta
zentiva pharma doo - dio stranog druŠtva podgorica - dasatinib - film tableta - 100mg
dasatinib zentiva 20mg film tableta
zentiva pharma doo - dio stranog druŠtva podgorica - dasatinib - film tableta - 20mg
vitekta
gilead sciences international ltd - elvitegravir - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - vitekta primjenjuje istodobno s inhibitor proteaza i drugi antiretrovirusni lijekovi, je indiciran za liječenje ljudski immunodeficiency virus 1 (hiv-1) infekcije u odraslih koji su zaraženi sa hiv-1 bez poznate mutacije povezanih s rezistencijom na elvitegravir.